Erythropoietin Terminated Phase 2 Trials for Human Immunodeficiency Virus (HIV) / Anemias Treatment

TerminatedTreatment2 IdentifierTitleDrugs
NCT00246298A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients
NCT00210626Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
NCT00240734Treatment of Anemia in Diabetic Subjects With CKD